---
title: "Silence Therapeutics closes upsized $201.3 million ADS follow-on offering at $13.5 each"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295975817.md"
description: "Silence Therapeutics completed an upsized follow-on offering of 14,907,407 ADSs at $13.5 each, raising approximately $201.3 million in gross proceeds. The deal included the full exercise of underwriters' options for an additional 1,944,444 ADSs. Each ADS represents three ordinary shares."
datetime: "2026-08-14T20:55:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295975817.md)
  - [en](https://longbridge.com/en/news/295975817.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295975817.md)
generator: "portal-rs"
---

# Silence Therapeutics closes upsized $201.3 million ADS follow-on offering at $13.5 each

-   Silence Therapeutics closed an upsized underwritten public offering of 14,907,407 ADSs at $ 13.5 per ADS. \* Gross proceeds totaled about $ 201.3 million before underwriting discounts, commissions, and offering expenses. \* Deal size included the full exercise of underwriters’ option for an additional 1,944,444 ADSs. \* Each ADS represents three ordinary shares of £0.05 each. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silence Therapeutics plc published the original content used to generate this news brief via Business Wire (Ref. ID: 202608141655BIZWIRE\_USPR\_\_\_\_\_20260814\_BW817164) on August 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [SLN.US](https://longbridge.com/en/quote/SLN.US.md)

## Related News & Research

- [Silence Therapeutics: Divesiran achieves best-in-class efficacy in PV, driving a strong siRNA pipeline and outlook](https://longbridge.com/en/news/297941659.md)
- [Silence Therapeutics 10% owner Richard Ian Griffiths disposes of ADS worth $87.88 million](https://longbridge.com/en/news/295812569.md)
- [MEDIROM Healthcare Technologies - ADS reports Q2 results](https://longbridge.com/en/news/297232356.md)
- [Quoin Pharma prices unregistered $50 million private placement at $4.88 per ADS](https://longbridge.com/en/news/297303248.md)
- [NetEase grants 224,739 ADS share awards under 2019 incentive plan](https://longbridge.com/en/news/297327426.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**